AAAAAA

   
Results: 1-17 |
Results: 17
EVALUATION OF CLINICAL-RESPONSE TO NEOADJUVANT CHEMOTHERAPY OF LARGE PRIMARY BREAST-TUMORS (GREATER-THAN-OR-EQUAL-TO-3.5 CM) AND CORRELATION WITH MAGNETIC-RESONANCE-IMAGING
Authors: COCQUYT V VILLEIRS G DEPYPERE HT VANDENBROECKE R SERREYN R MORTIER M VANBELLE S
Citation: V. Cocquyt et al., EVALUATION OF CLINICAL-RESPONSE TO NEOADJUVANT CHEMOTHERAPY OF LARGE PRIMARY BREAST-TUMORS (GREATER-THAN-OR-EQUAL-TO-3.5 CM) AND CORRELATION WITH MAGNETIC-RESONANCE-IMAGING, European journal of cancer, 34, 1998, pp. 74-74
ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) FOR EARLY BREAST-CANCER - 13 YEARS UPDATE OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) FOR EARLY BREAST-CANCER - 13 YEARS UPDATE OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 34, 1998, pp. 102-102
OSSIFIED RETROPERITONEAL MALIGNANT SCHWANNOMA WITH SPINAL LEPTOMENINGEAL METASTASES
Authors: MORTELE K LEMMERLING M DEFREYNE L SPELEMAN F DEPOTTER C VANBELLE S KUNNEN M
Citation: K. Mortele et al., OSSIFIED RETROPERITONEAL MALIGNANT SCHWANNOMA WITH SPINAL LEPTOMENINGEAL METASTASES, Neuroradiology, 40(1), 1998, pp. 48-50
IMPLEMENTATION OF A POLICY OF PREOPERATIVE RADIATION-THERAPY AND TOTAL MESORECTAL EXCISION IN RECTAL-CANCER TREATMENT
Authors: CEELEN W CARDON A PATTYN P HESSE UJ DEVOS M DENEVE W VANBELLE S DEHEMPTINNE B
Citation: W. Ceelen et al., IMPLEMENTATION OF A POLICY OF PREOPERATIVE RADIATION-THERAPY AND TOTAL MESORECTAL EXCISION IN RECTAL-CANCER TREATMENT, British Journal of Surgery, 85, 1998, pp. 14-14
ONDANSETRON SUPPOSITORY - A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP COMPARISON WITH ORAL ONDANSETRON FOR THE PREVENTION OF CYCLOPHOSPHAMIDE-INDUCED EMESIS AND NAUSEA
Authors: DAVIDSON NGP PASKA W VANBELLE S GOEDHALS L MCQUADE B MCRAE J
Citation: Ngp. Davidson et al., ONDANSETRON SUPPOSITORY - A RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP COMPARISON WITH ORAL ONDANSETRON FOR THE PREVENTION OF CYCLOPHOSPHAMIDE-INDUCED EMESIS AND NAUSEA, Oncology, 54(5), 1997, pp. 380-386
TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY
Authors: CREEMERS GJ BOLIS G GORE M SCARFONE G LACAVE AJ GUASTALLA JP DESPAX R FAVALLI G KREINBERG R VANBELLE S HUDSON I VERWEIJ J HUININK WWT
Citation: Gj. Creemers et al., TOPOTECAN, AN ACTIVE-DRUG IN THE 2ND-LINE TREATMENT OF EPITHELIAL OVARIAN-CANCER - RESULTS OF A LARGE EUROPEAN PHASE-II STUDY, Journal of clinical oncology, 14(12), 1996, pp. 3056-3061
INCREASING SERUM LEVELS OF ALPHA-FETOPROTEIN IN A PATIENT WITH RELAPSING GALLBLADDER CARCINOMA
Authors: COCQUYT V PIPELEERSMARICHAL M DELVAUX G VANBELLE S
Citation: V. Cocquyt et al., INCREASING SERUM LEVELS OF ALPHA-FETOPROTEIN IN A PATIENT WITH RELAPSING GALLBLADDER CARCINOMA, American journal of clinical oncology, 19(5), 1996, pp. 465-468
DO RADIOSENSITIZERS ENHANCE THE TREATMENT OF PATIENTS WITH NSCLC - THE NEED FOR BETTER MODELS AND ALTERNATIVE METHODS OF TREATMENT
Authors: VANBELLE S
Citation: S. Vanbelle, DO RADIOSENSITIZERS ENHANCE THE TREATMENT OF PATIENTS WITH NSCLC - THE NEED FOR BETTER MODELS AND ALTERNATIVE METHODS OF TREATMENT, Chest, 109(5), 1996, pp. 115-118
UNEXPECTED OPPOSITE AGE-RELATED EFFECT OF ADJUVANT HIGH-DOSE PROGESTERONE ACETATE (HD-MPA) FOR NODE-POSITIVE (NP) EARLY BREAST-CANCER - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., UNEXPECTED OPPOSITE AGE-RELATED EFFECT OF ADJUVANT HIGH-DOSE PROGESTERONE ACETATE (HD-MPA) FOR NODE-POSITIVE (NP) EARLY BREAST-CANCER - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 46-46
IMPROVEMENT OF PROGNOSIS IRRESPECTIVE OF AGE IN EARLY NODE-NEGATIVE EARLY BREAST-CANCER BY ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL
Authors: FOCAN C BEAUDUIN M SALAMON E DEGREVE J DEWASCH G LOBELLE JP MAJOIS F TAGNON A TYTGAT J VANBELLE S VANDERVELLEN R VINDEVOGHEL A
Citation: C. Focan et al., IMPROVEMENT OF PROGNOSIS IRRESPECTIVE OF AGE IN EARLY NODE-NEGATIVE EARLY BREAST-CANCER BY ADJUVANT HIGH-DOSE MEDROXYPROGESTERONE ACETATE (HD-MPA) - 10 YEARS RESULTS OF A MULTICENTER RANDOMIZED TRIAL, European journal of cancer, 31A, 1995, pp. 56-56
AN OPEN, COMPARATIVE RANDOMIZED TRIAL COMPARING FORMESTANE VS ORAL MEGESTROL-ACETATE AS A 2ND-LINE THERAPY IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS
Authors: ROSE C FREUE M KJAER M BONI C JANICKE F COOMBES C WILLEMSE PHB VANBELLE S CARRION RP DEPALACIOS PI
Citation: C. Rose et al., AN OPEN, COMPARATIVE RANDOMIZED TRIAL COMPARING FORMESTANE VS ORAL MEGESTROL-ACETATE AS A 2ND-LINE THERAPY IN POSTMENOPAUSAL ADVANCED BREAST-CANCER PATIENTS, European journal of cancer, 31A, 1995, pp. 352-352
ONDANSETRON (OND) SUPPOSITORY (SUP) - AN EFFECTIVE TREATMENT IN THE PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS
Authors: FUMOLEAU P GIOVANNINI M DAVIDSON NGP VANBELLE S GOEDHALS L VOTAN B PASKA W
Citation: P. Fumoleau et al., ONDANSETRON (OND) SUPPOSITORY (SUP) - AN EFFECTIVE TREATMENT IN THE PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS, European journal of cancer, 31A, 1995, pp. 1218-1218
PATTERNS OF AXILLARY LYMPH-NODE METASTASIS IN BREAST-CANCER
Authors: VANLANCKER M GOOR C SACRE R LAMOTE J VANBELLE S DECOENE N ROELSTRAETE A STORME G
Citation: M. Vanlancker et al., PATTERNS OF AXILLARY LYMPH-NODE METASTASIS IN BREAST-CANCER, American journal of clinical oncology, 18(3), 1995, pp. 267-272
OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: HULSTAERT F VANBELLE S BLEIBERG H CANON JL DEWITTE M BUYSE M DEKEYSER P WESTELINCK KJ
Citation: F. Hulstaert et al., OPTIMAL COMBINATION THERAPY WITH TROPISETRON IN 445 PATIENTS WITH INCOMPLETE CONTROL OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Journal of clinical oncology, 12(11), 1994, pp. 2439-2446
INTERACTION BETWEEN VINBLASTINE AND IONIZING-RADIATION IN THE MOUSE MO(4) FIBROSARCOMA IN-VIVO
Authors: VANBELLE S FORTAN L DESMET M DENEVE W VANDERELST J STORME G
Citation: S. Vanbelle et al., INTERACTION BETWEEN VINBLASTINE AND IONIZING-RADIATION IN THE MOUSE MO(4) FIBROSARCOMA IN-VIVO, Anticancer research, 14(3A), 1994, pp. 1043-1048
COMPASSIONATE USE OF TROPISETRON IN PATIENTS AT HIGH-RISK OF SEVERE EMESIS
Authors: BLEIBERG H VANBELLE S PARIDAENS R DEWASCH G DIRIX LY TJEAN M
Citation: H. Bleiberg et al., COMPASSIONATE USE OF TROPISETRON IN PATIENTS AT HIGH-RISK OF SEVERE EMESIS, Annals of oncology, 4, 1993, pp. 190000043-190000045
5'-NOR-ANHYDROVINBLASTINE (NAVELBINE(R)) HAS AN ANTI-INVASIVE EFFECT ON MO4 MOUSE FIBROSARCOMA CELLS-INVITRO AND INVIVO
Authors: VANDENBERGE D BRUYNEEL E DISTELMANS W VANBELLE S KRIKONIAN A BREILLOUT F STORME G
Citation: D. Vandenberge et al., 5'-NOR-ANHYDROVINBLASTINE (NAVELBINE(R)) HAS AN ANTI-INVASIVE EFFECT ON MO4 MOUSE FIBROSARCOMA CELLS-INVITRO AND INVIVO, Anticancer research, 13(1), 1993, pp. 273-278
Risultati: 1-17 |